Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › IN › Indianapolis › NPI 1821670704
Lab

Genepace Laboratories, LLC.

Genepace Laboratories, LLC. was paid $53K by Medicaid between Mar 2021 and Jan 2023, across 4 billing codes. Its largest line is U0004, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r — 73% of everything it billed.

33Billing provider infoGENEPACE LABORATORIES, LLC.
INDIANAPOLIS, IN 46202
33aNPI1821670704assigned 04/21/2021
28Total paid$53K
24GClaims3,206
24DCodes billed4
24AFirst – last monthMar 2021 – Jan 2023
Compared with peers

Next to other Clinical Medical Laboratory providers in Indiana

Rank by total paid#34 of 66
Median peer was paid$53K
This provider vs. median1.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$10K$20K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20211,414$29K
20221,075$24K
2023717$0.00
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 73% 1,361 829 $39K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 23% 1,342 817 $12K
G2024 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source 1.9% 404 138 $975.60
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 1.7% 99 67 $888.19

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialGEORGE, MULAMOOTTIL (CHIEF SCIENTIFIC OFFICER)